Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07577999 · ClinicalTrials.gov registry record · Early Phase 1
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
A Early Phase 1 study, sponsored by Stanford University.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT07577999: Clinical Trial Early Phase 1 study, sponsored by Stanford University.
NCT07577999 is a Early Phase 1 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07577999, a Early Phase 1 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).
Interventions
- DRUG Cannabigerol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2027-07 |
| Est. Completion | 2028-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07577999
The ClinicalTrials.gov registry entry for NCT07577999 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabigerol is the first listed.
NCT07577999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07577999 about?
NCT07577999 is a clinical study titled "The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy". This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplemen...
What is the current status of trial NCT07577999?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2027-07. Estimated completion is 2028-05.
What interventions are being tested in trial NCT07577999?
The interventions under investigation include: Cannabigerol (DRUG).
Who is sponsoring clinical trial NCT07577999?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.